Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 17;31(11):1647-1650.
doi: 10.1097/QAD.0000000000001551.

Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis

Richard E Haaland  1 , Amy Martin, Angela Holder, Jeffrey J Fountain, LaShonda Hall, Nicole A Pescatore, Sheila Heeke, Colleen F Kelley
Affiliations

Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis

Richard E Haaland et al. AIDS. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Figures

Fig. 1
Fig. 1. TFV and FTC concentrations in urine compared to plasma following seven days of oral Truvada
TFV (white boxes) and FTC (gray boxes) concentrations were measured in urine and plasma specimens collected from MSM (a). Urine FTC concentrations correlate with plasma concentrations in paired specimens (b). TFV urine concentrations were compared with plasma concentrations in paired specimens (c). FTC, emtricitabine; TFV, tenofovir.
See this image and copyright information in PMC

References

    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–2599. - PMC - PubMed
    1. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–434. - PubMed
    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410. - PMC - PubMed
    1. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. ANRS IPERGAY Study Group. Ondemand preexposure prophylaxis in men at high risk for hiv-1 infection. N Engl J Med. 2015;373:2237–2246. - PubMed
    1. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. iPrEx Study Team. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4:151ra125. - PMC - PubMed

Publication types